Warning letter · FDA Warning Letters, Historical Archive

Center for Wellness and Integrative Medicine: FDA Warning Letter 608693 (Jun 30, 2020)

Agency action: Jun 30, 2020Record ID: fda_warning_-7713ee0bc5d47797
View official source ↗

What happened

Original notice title

Center for Wellness and Integrative Medicine MARCS-CMS 608693, June 30, 2020

From the archived source record

Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352. We request that you take immediate action to cease the sale of such unapproved and unauthorized products for the mitigation, prevention, treatment, diagnosis, or cure of COVID-19. Some examples of the claims on your website that establish the intended use of your products and misleadingly represent them as safe and/or effective for the treatment or prevention of COVID-19 include: On a webpage titled “COVID Household Value Pack,” you represent the following: “I recommend each and every family purchase the ‘4 Horsemen’ to outrun the tide of COVID. . . . Currently, IV Vitamin C is under clinical trials in Shanghai for COVID hospitalized patients.” “Vitamin D3 . . . I’m recommending individuals which [sic] chronic immune debility use this for 3-4 months during the oncoming tide of COVID infections.” From a March 22, 2020 post: “#1 Easiest way to prevent Coronavirus exposure from developing into severe COVID infection: Vitamin C.” You should take immediate action to correct the violations cited in this letter. This letter is not meant to be an all-inclusive list of violations that exist in connection with your products or operations. We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that you are not misleadingly representing your products as safe and effective for a COVID-19-related use for which they have not been approved by FDA and that you do not make claims that misbrand the products in violation of the FD&C Act . Within 48 hours, please send an email to COVID-19-Task-Force-CDER@fda.hhs.gov describing the specific steps you have taken to correct these violations.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Historical warning letter; closeout not established by annual index
Source checked
Jul 16, 2026
Record revision
09ae1b9ce156

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
COVID Supplement Protection Pack; COVID Household Value Pack; Supplies; a “COVID Supplement Protection Pack” (also referred to as the “COVID Household Value Pack”); Thymosin-Alpha; and Methylene Blue Capsules
Company
Center for Wellness and Integrative Medicine
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.